Upcoming Reports [full schedule to be confirmed]
Schedule of Publications 2022
2022
Nov
MAIN Mental health
Mental Health Edition
Published
MAIN Neuroscience with subanalyses
Neurological Edition
Published
Oct
MAIN Autoimmune with subanalyses
Autoimmune Edition
Published
MAIN Respiratory
Respiratory Edition
Published
Sep
MAIN Rare diseases with Bleeding disorders as subanalyses
Rare Diseases Edition
Published
MAIN Italy
Italy Edition
Published
MAIN Spain
Spain Edition
Published
Aug
MAIN Asia
Asia Edition
Published
MAIN Germany
Germany Edition
Published
Jul
MAIN UK
UK Edition
Published
MAIN France
France Edition
Published
Jun
ESG report
Published
MAIN Canada
Canada Edition
Published
MAIN HIV/AIDS
HIV/AIDS Edition
Published
May
MAIN Cancer [including subanalyses]
Cancer Edition
Published
MAIN USA
USA Edition
Published
Apr
MAIN Global
Global Edition
Published
2021
Oct
Corporate Reputation of Pharma 2021 – mental health edition
Mental Health Edition
Published
Corporate Reputation of Pharma 2021 – neurological edition
Neurological Edition
Published
Corporate Reputation of Pharma 2021 – autoimmune edition
Autoimmune Edition
Published
Sep
Corporate Reputation of Pharma 2021 – Respiratory Edition
Respiratory Edition
Published
Corporate Reputation of Pharma 2021 – Bleeding Disorders Edition
Bleeding disorders edition, Rare Diseases Edition
Published
Corporate Reputation of Pharma 2021 – Spain Edition
Spain Edition
Published
Corporate Reputation of Pharma 2021 – Italy Edition
Italy Edition
Published
Aug
Realigning Patient Centricity Strategies after a pandemic
Toolkits for Pharma
Published
Corporate Reputation of Pharma 2021 – Asia Edition
Asia Edition
Published
Jul
Corporate Reputation of Pharma 2021 – Germany Edition
Germany Edition
Published
Corporate Reputation of Pharma 2021 – UK Edition
UK Edition
Published
Corporate Reputation of Pharma 2021 – France Edition
France Edition
Published
Jun
Corporate Reputation of Pharma 2021 – Canada Edition
Canada Edition
Published
Corporate Reputation of Pharma 2021 – HIV/AIDS Edition
HIV/AIDS Edition
Published
May
Corporate Reputation of Pharma 2021 – Cancer Edition
Cancer Edition
Published
Corporate Reputation of Pharma 2021 – USA Edition
USA Edition
Published
Apr
Corporate Reputation of Pharma 2021 – Global Edition
Global Edition
Published
2020
Sep
Patient relations
The Experience of PATIENT ORGANISATIONS During the Covid-19 Global Pandemic
Published